|
GFOR | Nkgen Biotech, Inc. |
|
|
GFOR | Nkgen Biotech, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ -0.75 |
| Leverage | 413.77% |
| Market Cap | $ 62.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -62.6m |
| Margin | 2309.41% |